☰

Robert B. Rebhun, Ph.D. - Publications

Affiliations: 
2006 The University of Texas Graduate School of Biomedical Sciences at Houston 
Area:
Oncology, Molecular Biology, Cell Biology
Tree Info Grants Similar researchers PubMed Report error

41 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Judge SJ, Yanagisawa M, Sturgill IR, Bateni SB, Gingrich AA, Foltz JA, Lee DA, Modiano JF, Monjazeb AM, Culp WTN, Rebhun RB, Murphy WJ, Kent MS, Canter RJ. Blood and tissue biomarker analysis in dogs with osteosarcoma treated with palliative radiation and intra-tumoral autologous natural killer cell transfer. Plos One. 15: e0224775. PMID 32084139 DOI: 10.1371/Journal.Pone.0224775  0.38
2019 Nam A, Kim T, Li Q, Rebhun RB, Youn HY, Seo KW. Melarsomine suppresses canine osteosarcoma cell survival via inhibition of Hedgehog-GLI signaling. The Journal of Veterinary Medical Science. PMID 31645504 DOI: 10.1292/Jvms.19-0043  0.366
2019 Kent MS, Emami S, Rebhun R, Theon A, Hansen K, Sparger E. The effects of local irradiation on circulating lymphocytes in dogs receiving fractionated radiotherapy. Veterinary and Comparative Oncology. PMID 31424596 DOI: 10.1111/Vco.12531  0.319
2019 Withers SS, York D, Choi JW, Woolard KD, Laufer-Amorim R, Sparger EE, Burton JH, McSorley SJ, Monjazeb AM, Murphy WJ, Canter RJ, Rebhun RB. Metastatic Immune Infiltrates Correlate with Those of the Primary Tumor in Canine Osteosarcoma. Veterinary and Comparative Oncology. PMID 30684301 DOI: 10.1111/Vco.12459  0.362
2018 Griffin MA, Culp WTN, Rebhun RB. Lower Urinary Tract Neoplasia. Veterinary Sciences. 5. PMID 30486368 DOI: 10.3390/Vetsci5040096  0.337
2018 Al-Nadaf S, Rebhun RB, Curran KM, Venable RO, Skorupski KA, Willcox JL, Burton JH. Retrospective analysis of doxorubicin and prednisone as first-line therapy for canine B-cell lymphoma. Bmc Veterinary Research. 14: 356. PMID 30458771 DOI: 10.1186/S12917-018-1688-5  0.377
2018 Shin H, Nam A, Song KH, Lee K, Rebhun RB, Seo KW. Anticancer effects of high-dose ascorbate on canine melanoma cell lines. Veterinary and Comparative Oncology. PMID 30188000 DOI: 10.1111/Vco.12429  0.332
2018 Withers SS, Skorupski KA, York D, Choi JW, Woolard KD, Laufer-Amorim R, Sparger EE, Rodriguez CO, McSorley SJ, Monjazeb AM, Murphy WJ, Canter RJ, Rebhun RB. Association of Macrophage and Lymphocyte Infiltration with Outcome in Canine Osteosarcoma. Veterinary and Comparative Oncology. PMID 30156029 DOI: 10.1111/Vco.12444  0.339
2018 Withers SS, York D, Johnson E, Al-Nadaf S, Skorupski KA, Rodriguez CO, Burton JH, Guerrero T, Sein K, Wittenburg L, Rebhun RB. In vitro and in vivo activity of liposome-encapsulated curcumin for naturally occurring canine cancers. Veterinary and Comparative Oncology. PMID 30088848 DOI: 10.1111/Vco.12424  0.369
2018 Skorupski KA, Alarcón CN, de Lorimier LP, LaDouceur EEB, Rodriguez CO, Rebhun RB. Outcome and clinical, pathological, and immunohistochemical factors associated with prognosis for dogs with early-stage anal sac adenocarcinoma treated with surgery alone: 34 cases (2002-2013). Journal of the American Veterinary Medical Association. 253: 84-91. PMID 29911942 DOI: 10.2460/Javma.253.1.84  0.387
2017 Moore EL, Vernau W, Rebhun RB, Skorupski KA, Burton JH. Patient characteristics, prognostic factors and outcome of dogs with high-grade primary mediastinal lymphoma. Veterinary and Comparative Oncology. PMID 28660709 DOI: 10.1111/Vco.12331  0.375
2017 Murphy BG, Mok MY, York D, Rebhun R, Woolard KD, Hillman C, Dickinson P, Skorupski K. Evaluation of P16 expression in canine appendicular osteosarcoma. Bmc Veterinary Research. 13: 189. PMID 28633676 DOI: 10.1186/S12917-017-1113-5  0.38
2016 Park JS, Withers SS, Modiano JF, Kent MS, Chen M, Luna JI, Culp WT, Sparger EE, Rebhun RB, Monjazeb AM, Murphy WJ, Canter RJ. Canine cancer immunotherapy studies: linking mouse and human. Journal For Immunotherapy of Cancer. 4: 97. PMID 28031824 DOI: 10.1186/S40425-016-0200-7  0.325
2016 York D, Withers SS, Watson KD, Seo KW, Rebhun RB. Enrofloxacin enhances the effects of chemotherapy in canine osteosarcoma cells with mutant and wild-type p53. Veterinary and Comparative Oncology. PMID 27333821 DOI: 10.1111/Vco.12250  0.359
2016 Skorupski KA, Uhl JM, Szivek A, Allstadt Frazier SD, Rebhun RB, Rodriguez CO. Carboplatin versus alternating carboplatin and doxorubicin for the adjuvant treatment of canine appendicular osteosarcoma: a randomized, phase III trial. Veterinary and Comparative Oncology. 14: 81-7. PMID 24118677 DOI: 10.1111/Vco.12069  0.337
2015 Shahi MH, York D, Gandour-Edwards R, Withers SS, Holt R, Rebhun RB. BMI1 is expressed in canine osteosarcoma and contributes to cell growth and chemotherapy resistance. Plos One. 10: e0131006. PMID 26110620 DOI: 10.1371/Journal.Pone.0131006  0.367
2015 Collette SA, Allstadt SD, Chon EM, Smith AN, Garrett LD, Choy K, Rebhun RB, Rodriguez CO, Skorupski KA. Treatment of feline intermediate- to high-grade lymphoma with a modified university of Wisconsin-Madison protocol: 119 cases (2004-2012). Veterinary and Comparative Oncology. PMID 26109275 DOI: 10.1111/Vco.12158  0.332
2015 Budreckis DM, Byrne BA, Pollard RE, Rebhun RB, Rodriguez CO, Skorupski KA. Bacterial urinary tract infections associated with transitional cell carcinoma in dogs. Journal of Veterinary Internal Medicine / American College of Veterinary Internal Medicine. 29: 828-33. PMID 25940672 DOI: 10.1111/Jvim.12578  0.337
2015 Allstadt SD, Rodriguez CO, Boostrom B, Rebhun RB, Skorupski KA. Randomized phase III trial of piroxicam in combination with mitoxantrone or carboplatin for first-line treatment of urogenital tract transitional cell carcinoma in dogs. Journal of Veterinary Internal Medicine / American College of Veterinary Internal Medicine. 29: 261-7. PMID 25619518 DOI: 10.1111/Jvim.12533  0.365
2015 Shahi MH, Zazpe I, Afzal M, Sinha S, Rebhun RB, Meléndez B, Rey JA, Castresana JS. Epigenetic regulation of human hedgehog interacting protein in glioma cell lines and primary tumor samples. Tumour Biology : the Journal of the International Society For Oncodevelopmental Biology and Medicine. 36: 2383-91. PMID 25416442 DOI: 10.1007/S13277-014-2846-4  0.345
2015 Lejeune A, Skorupski K, Frazier S, Vanhaezebrouck I, Rebhun RB, Reilly CM, Rodriguez CO. Aggressive local therapy combined with systemic chemotherapy provides long-term control in grade II stage 2 canine mast cell tumour: 21 cases (1999-2012). Veterinary and Comparative Oncology. 13: 267-80. PMID 23721492 DOI: 10.1111/Vco.12042  0.334
2015 Withers SS, Johnson EG, Culp WT, Rodriguez CO, Skorupski KA, Rebhun RB. Paraneoplastic hypertrophic osteopathy in 30 dogs. Veterinary and Comparative Oncology. 13: 157-65. PMID 23489591 DOI: 10.1111/Vco.12026  0.32
2014 Culp WT, Olea-Popelka F, Sefton J, Aldridge CF, Withrow SJ, Lafferty MH, Rebhun RB, Kent MS, Ehrhart N. Evaluation of outcome and prognostic factors for dogs living greater than one year after diagnosis of osteosarcoma: 90 cases (1997-2008). Journal of the American Veterinary Medical Association. 245: 1141-6. PMID 25356715 DOI: 10.2460/Javma.245.10.1141  0.339
2014 Withers SS, Kass PH, Rodriguez CO, Skorupski KA, O'Brien D, Guerrero TA, Sein KD, Rebhun RB. Fasting Reduces the Incidence of Delayed-Type Vomiting Associated with Doxorubicin Treatment in Dogs with Lymphoma. Translational Oncology. PMID 24831580 DOI: 10.1016/J.Tranon.2014.04.014  0.355
2014 Shahi MH, Holt R, Rebhun RB. Blocking signaling at the level of GLI regulates downstream gene expression and inhibits proliferation of canine osteosarcoma cells. Plos One. 9: e96593. PMID 24810746 DOI: 10.1371/Journal.Pone.0096593  0.361
2014 Seo KW, Coh YR, Rebhun RB, Ahn JO, Han SM, Lee HW, Youn HY. Antitumor effects of celecoxib in COX-2 expressing and non-expressing canine melanoma cell lines. Research in Veterinary Science. 96: 482-6. PMID 24656746 DOI: 10.1016/J.Rvsc.2014.03.003  0.389
2014 Boostrom BO, Good KL, Maggs DJ, Rebhun RB, Johns JL, Kent MS. Unilateral intraocular mastocytosis and anterior uveitis in a dog with subcutaneous mast cell tumors. Veterinary Ophthalmology. 17: 131-8. PMID 23578200 DOI: 10.1111/Vop.12041  0.342
2013 O'Brien D, Moore PF, Vernau W, Peauroi JR, Rebhun RB, Rodriguez CO, Skorupski KA. Clinical characteristics and outcome in dogs with splenic marginal zone lymphoma. Journal of Veterinary Internal Medicine / American College of Veterinary Internal Medicine. 27: 949-54. PMID 23734665 DOI: 10.1111/Jvim.12116  0.376
2013 Culp WT, Ehrhart N, Withrow SJ, Rebhun RB, Boston S, Buracco P, Reiter AM, Schallberger SP, Aldridge CF, Kent MS, Mayhew PD, Brown DC. Results of surgical excision and evaluation of factors associated with survival time in dogs with lingual neoplasia: 97 cases (1995-2008). Journal of the American Veterinary Medical Association. 242: 1392-7. PMID 23634684 DOI: 10.2460/Javma.242.10.1392  0.397
2012 Seo Kw, Holt R, Jung YS, Rodriguez CO, Chen X, Rebhun RB. Fluoroquinolone-mediated inhibition of cell growth, S-G2/M cell cycle arrest, and apoptosis in canine osteosarcoma cell lines. Plos One. 7: e42960. PMID 22927942 DOI: 10.1371/Journal.Pone.0042960  0.335
2012 Balhorn R, Rebhun RB, Hok S, Baum R, Sanger J, Balhorn MC. Abstract 4591: Biotinylated derivatives of selective high affinity ligand (SHAL) therapeutics as companion diagnostics for prescreening non-Hodgkin's lymphoma patients Cancer Research. 72: 4591-4591. DOI: 10.1158/1538-7445.Am2012-4591  0.382
2011 Rebhun RB, Kent MS, Borrofka SA, Frazier S, Skorupski K, Rodriguez CO. CHOP chemotherapy for the treatment of canine multicentric T-cell lymphoma. Veterinary and Comparative Oncology. 9: 38-44. PMID 21303452 DOI: 10.1111/J.1476-5829.2010.00230.X  0.379
2010 Balhorn RL, Skorupski KA, Hok S, Balhorn MC, Guerrero T, Rebhun RB. A selective high affinity ligand (SHAL) designed to bind to an over-expressed human antigen on non-Hodgkin's lymphoma also binds to canine B-cell lymphomas Veterinary Immunology and Immunopathology. 137: 235-242. PMID 20576295 DOI: 10.1016/J.Vetimm.2010.05.014  0.342
2010 Rebhun RB, Cheng H, Gershenwald JE, Fan D, Fidler IJ, Langley RR. Constitutive expression of the alpha4 integrin correlates with tumorigenicity and lymph node metastasis of the B16 murine melanoma. Neoplasia (New York, N.Y.). 12: 173-82. PMID 20126475 DOI: 10.1593/Neo.91604  0.511
2010 Rebhun RB, Thamm DH. Multiple distinct malignancies in dogs: 53 cases. Journal of the American Animal Hospital Association. 46: 20-30. PMID 20045833 DOI: 10.5326/0460020  0.365
2008 Rebhun RB, Lana SE, Ehrhart EJ, Charles JB, Thamm DH. Comparative analysis of survivin expression in untreated and relapsed canine lymphoma. Journal of Veterinary Internal Medicine / American College of Veterinary Internal Medicine. 22: 989-95. PMID 18647159 DOI: 10.1111/J.1939-1676.2008.0143.X  0.422
2008 Sasaki T, Nakamura T, Rebhun RB, Cheng H, Hale KS, Tsan RZ, Fidler IJ, Langley RR. Modification of the primary tumor microenvironment by transforming growth factor alpha-epidermal growth factor receptor signaling promotes metastasis in an orthotopic colon cancer model. The American Journal of Pathology. 173: 205-16. PMID 18583324 DOI: 10.2353/Ajpath.2008.071147  0.502
2008 Rebhun RB, Lazar AJ, Fidler IJ, Gershenwald JE. Impact of sentinel lymphadenectomy on survival in a murine model of melanoma. Clinical & Experimental Metastasis. 25: 191-9. PMID 18264782 DOI: 10.1007/S10585-008-9141-Y  0.503
2006 Rebhun RB, Langley RR, Yokoi K, Fan D, Gershenwald JE, Fidler IJ. Targeting receptor tyrosine kinase on lymphatic endothelial cells for the therapy of colon cancer lymph node metastasis. Neoplasia (New York, N.Y.). 8: 747-57. PMID 16984732 DOI: 10.1593/Neo.06322  0.535
2005 Thaker PH, Yokoi K, Jennings NB, Li Y, Rebhun RB, Rousseau DL, Fan D, Sood AK. Inhibition of experimental colon cancer metastasis by the GABA-receptor agonist nembutal. Cancer Biology & Therapy. 4: 753-8. PMID 15970706 DOI: 10.4161/Cbt.4.7.1827  0.319
2004 Langley RR, Fan D, Tsan RZ, Rebhun R, He J, Kim SJ, Fidler IJ. Activation of the platelet-derived growth factor-receptor enhances survival of murine bone endothelial cells. Cancer Research. 64: 3727-30. PMID 15172974 DOI: 10.1158/0008-5472.Can-03-3863  0.491
Show low-probability matches.